Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trial-Reference-Cited by-同舟云学术

Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trial

Published:2022-09 Issue:9 Volume:9 Page:e660-e669
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

DeZern Amy E,Eapen Mary,Wu Juan,Talano Julie-An,Solh Melhem,Dávila Saldaña Blachy J,Karanes Chatchada,Horwitz Mitchell E,Mallhi Kanwaldeep,Arai Sally,Farhadfar Nosha,Hexner Elizabeth,Westervelt Peter,Antin Joseph H,Deeg H Joachim,Leifer Eric,Brodsky Robert A,Logan Brent R,Horowitz Mary M,Jones Richard J,Pulsipher Michael A

Publisher

Elsevier BV

Subject

Hematology

Reference31 articles.

1. How I treat acquired aplastic anemia;Bacigalupo;Blood,2017

2. Myelodysplastic syndrome evolving from aplastic anemia treated with immunosuppressive therapy: efficacy of hematopoietic stem cell transplantation;Kim;Haematologica,2014

3. Eltrombopag added to standard immunosuppression for aplastic anemia;Townsley;N Engl J Med,2017

4. A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA Working Party of the European Group for Blood and Marrow Transplantation;Tichelli;Blood,2011

5. Long-term outcomes in severe aplastic anemia patients treated with immunosuppression and eltrombopag: a phase 2 study;Patel;Blood,2022

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term survival after unrelated donor marrow transplantation for aplastic anaemia after optimized conditioning regimen: a retrospective multicentre cohort study;eClinicalMedicine;2024-10

2. Comparison of hematopoietic stem cell transplantation and repeated intensified immunosuppressive therapy as second-line treatment for relapsed/refractory severe aplastic anemia;Frontiers in Immunology;2024-08-16

3. Efficacy of a Modified Post-Transplant Cyclophosphamide Regimen for Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients with Severe Aplastic Anemia: A Prospective Study;Transplantation and Cellular Therapy;2024-08

4. Modified Delphi panel consensus recommendations for management of severe aplastic anemia;Blood Advances;2024-07-26

5. Comparison of atrial fibrillation prevalence and in-hospital cardiovascular outcomes between patients undergoing allogeneic versus autologous hematopoietic stem cell transplantation: insights from the national inpatient sample;Scientific Reports;2024-07-22